Stockreport

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) and Sanofi SA's (NASDAQ: SNY ) Dupixent recently gained FDA approval for COPD, marking its sixth U.S. indication since its [Read more]